Bornaprine
From Wikipedia, the free encyclopedia
![]() |
|
Clinical data | |
---|---|
Trade names | Sormodren |
AHFS/Drugs.com | International Drug Names |
Routes of administration |
By mouth (tablets) |
ATC code | N04AA11 (WHO) |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | 96% |
Metabolism | Extensive |
Excretion | Urine (mainly)[1] |
Identifiers | |
|
|
CAS Number | 20448-86-6 26908-91-8 |
PubChem (CID) | 30160 |
ChemSpider | 28011 ![]() |
UNII | 9M363FGA7J ![]() |
KEGG | D07302 |
ChEMBL | CHEMBL2104596 |
ECHA InfoCard | 100.205.286 |
Chemical and physical data | |
Formula | C21H31NO2 |
Molar mass | 329.476 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(verify) |
Bornaprine (brand name Sormodren) is an anticholinergic used as an antiparkinsonian agent.[2][3]
References[edit]
- ^ "Sormodren Tabletten" (PDF) (in German). BGP Products Ges.m.b.H. Perfektastraße 84A, 1230 Wien. Retrieved 30 August 2016.
- ^ Cantello, R.; Riccio, A.; Gilli, M.; Delsedime, M.; Scarzella, L.; Aguggia, M.; Bergamasco, B. (1986). "Bornaprine vs placebo in Parkinson disease: Double-blind controlled cross-over trial in 30 patients". Italian journal of neurological sciences. 7 (1): 139–143. doi:10.1007/BF02230432. PMID 3514543.
- ^ Jasek, W, ed. (2007). Austria-Codex (in German) (62nd ed.). Vienna: Österreichischer Apothekerverlag. ISBN 978-3-85200-181-4.
![]() |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |